The invention relates to an antineoplastic pharmaceutical composition and application thereof in preparing antineoplastic drugs. The antineoplastic pharmaceutical composition is characterized by comprising a compound and Sorafenib as shown in a formula I in the description, wherein the rate of the amount of substance of the compound to Sorafenib as shown in the formula I is (1-10):1, preferably 1:1. Please see the formula in the description.